Nikolay Sergeev

Nikolay Sergeev is an expert molecular biologist with the experience in launching commercial tests for infectious disease diagnostics, liquid biopsy and NIPT.

His experiences in leading cross-functional teams with the successful launch of qPCR and NGS-based LDT tests.

His Experience includes: Sr. Director, R&D at DiaCarta; Principal Scientist, Guardant Health; Principal Scientist at NVS Technologies and five years as a Staff Fellow at the Food & Drug Administration (FDA).